Swedish Pharmaceuticals & Biotech Top Growth Stocks

Camurus

Market Cap: SEK 33.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 17.6b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Guard Therapeutics International

Market Cap: SEK 23.8m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.5b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

IDL Diagnostics

Market Cap: SEK 89.1m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Biovica International

Market Cap: SEK 101.3m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.